checkAd

    EQS-Adhoc  212  0 Kommentare Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering Ready to Use Diclofenac Stick Packs - Seite 3

    RELIEF THERAPEUTICS Holding SA is listed on the SIX Swiss Exchange under the symbol RLF and quoted in the U.S. on OTCQB under the symbols RLFTF and RLFTY. For more information, visit www.relieftherapeutics.com.

    Follow us on LinkedIn.


    CONTACT:
    RELIEF THERAPEUTICS Holding SA

    Jack Weinstein
    Chief Financial Officer and Treasurer
    contact@relieftherapeutics.com

    FOR MEDIA/INVESTOR INQUIRIES:
    Rx Communications Group

    Michael Miller
    +1-917-633-6086
    mmiller@rxir.com
     

    Disclaimer: This communication expressly or implicitly contains certain forward-looking statements concerning RELIEF THERAPEUTICS Holding SA. Such statements involve certain known and unknown risks, uncertainties and other factors, including (i) whether and when the new patent will issue, (ii) whether the new patent will be upheld, if challenged, (iii) the scope of the protection ultimately afforded by the new patent, and (iv) those risks discussed in RELIEF THERAPEUTICS Holding SA's press releases and filings with the SIX, which could cause the actual results, financial condition, performance or achievements of RELIEF THERAPEUTICS Holding SA to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. RELIEF THERAPEUTICS Holding SA is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.


    Additional features:


    File: Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering Ready to Use Diclofenac Stick Packs

    End of ad hoc announcement
    Language: English
    Company: RELIEF THERAPEUTICS Holding AG
    Avenue de Sécheron 15
    1202 Genève
    Switzerland
    E-mail: contact@relieftherapeutics.com
    Internet: https://relieftherapeutics.com
    ISIN: CH0100191136
    Listed: SIX Swiss Exchange
    EQS News ID: 1271655
    Seite 3 von 4



    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-Adhoc Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering Ready to Use Diclofenac Stick Packs - Seite 3 EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Patent Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering Ready to Use Diclofenac Stick Packs …

    Schreibe Deinen Kommentar

    Disclaimer